Welcome to our dedicated page for Perrigo Co Plc SEC filings (Ticker: PRGO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Perrigo Company plc (NYSE: PRGO) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents filed with the Securities and Exchange Commission. Perrigo is incorporated in Ireland and files its reports as a foreign private issuer with ordinary shares listed on the New York Stock Exchange under the symbol PRGO.
Through its Form 8-K filings, Perrigo reports material events such as quarterly earnings releases, strategic reviews and significant transactions. Recent 8-Ks have furnished earnings results for its Consumer Self-Care Americas and Consumer Self-Care International segments, described non-GAAP measures such as adjusted operating income, adjusted diluted earnings per share, organic net sales and constant currency net sales, and outlined the items excluded in these non-GAAP metrics, including amortization of acquired intangibles, restructuring charges, unusual litigation, impairment charges, divestiture gains or losses and infant formula remediation.
Other 8-K filings detail corporate actions such as the entry into a Master Sale and Purchase Agreement to sell Perrigo’s Dermacosmetics branded business in Northern Europe, the Netherlands and Poland, and executive leadership changes and related compensation arrangements. These filings provide insight into how the company is managing its portfolio, capital allocation and organizational structure.
On Stock Titan, users can view Perrigo’s filings as they are made available from EDGAR and use AI-powered summaries to understand the main points of lengthy documents. This includes context around earnings-related disclosures, explanations of non-GAAP reconciliations and highlights from transaction agreements and governance updates. For investors tracking PRGO, this page serves as a centralized view of Perrigo’s regulatory reporting history and ongoing disclosure practices.
Geoffrey M. Parker, a director of Perrigo Company plc (PRGO), reported transactions dated 09/12/2025. He disposed of 28,912 ordinary shares and received 1,263 Restricted Stock Units that vest on 12 September 2026. After the reported transactions he beneficially owned 25,879 ordinary shares directly, plus 9,875 shares via a revocable trust and 9,875 shares via a Roth IRA as disclosed. The Form 4 was signed by an attorney-in-fact on 09/15/2025. Explanations clarify that each RSU converts to one ordinary share on vesting.
Bradley A. Alford, a director of Perrigo Company plc (PRGO), reported a sale and a grant on Form 4. The filing shows a disposition of 41,160.148 ordinary shares on 09/12/2025. The filing also reports acquisition of 1,263 Restricted Stock Units (RSUs) on 09/12/2025, each representing a contingent right to one ordinary share, with vesting on 12 September 2026. The RSUs are held directly. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Alford on 09/15/2025. The document does not state a sale price, remaining total ordinary shares owned after the sale, or the reason for the transactions.
Insider transactions at Perrigo Company plc (PRGO): An executive (EVP & CBDO) received 7,701 Restricted Stock Units that convert one-for-one into ordinary shares and were reported as acquired, while 2,784 ordinary shares were sold. After these transactions the reporting person beneficially owned 4,917 ordinary shares. The RSUs vest in two equal annual installments beginning on the report's transaction date, so further share delivery will occur over the next year as vesting conditions are met. The mix of a granted/vested equity award and a contemporaneous sale of company stock is consistent with routine executive compensation and portfolio management.
Abigail Lennox, EVP and CSO of Perrigo Company plc, reported acquiring 1,255 ordinary shares on 09/08/2025 at $22.41 per share, leaving her beneficial ownership at 1,255 shares. The Form 4 was signed by an attorney-in-fact and shows the transaction was a direct purchase.
Charles Atkinson, EVP, General Counsel & Secretary of Perrigo Company plc (PRGO), reported a personal purchase of 1,000 ordinary shares on 09/05/2025 at a price of $23.20 per share. After the transaction he beneficially owns 1,000 shares directly. The Form 4 was signed on behalf of Mr. Atkinson by an attorney-in-fact on 09/08/2025. No derivative transactions or other securities classes were reported on this filing.
Perrigo Company plc (PRGO) Form 3 filing by Matthew John Winterman. The filing notifies that Mr. Winterman, listed as EVP, Supply, Ops, Strategy and a director/officer, reported no beneficial ownership of Perrigo securities as of the event date 06/23/2025. The form is an initial Section 16 filing and was signed by an attorney-in-fact on behalf of Mr. Winterman on 08/22/2025. No derivative or non-derivative securities are reported.
Perrigo Company plc (PRGO) insider purchase disclosed on 08/22/2025. Robert Willis, EVP & CHRO and an officer of the company, purchased 1,488 ordinary shares in open-market transactions at a weighted average price of $24.098 per share (individual trade prices ranged from $24.06 to $24.18). After the purchases, Mr. Willis beneficially owns 41,939 shares. The filing was executed by an attorney-in-fact and includes an undertaking to provide details of the number of shares bought at each price upon request. No derivative transactions or other changes in ownership were reported.
Perrigo Company plc (PRGO) Form 4/A corrects an earlier filing to show that on 08/18/2025 the reporting person, Geoffrey M. Parker, had 4,375 ordinary shares acquired at a price of $22.9708, and those shares were acquired indirectly by the Geoffrey M. Parker Roth IRA rather than directly. After this transaction the Roth IRA held 9,875 shares. The filing also lists other holdings: 28,912 ordinary shares disposed (as reported) and 25,879 ordinary shares held indirectly via a revocable trust in which Geoffrey and Jill Parker are trustees. The amendment states the only change from the original Form 4 is correcting the manner of acquisition to reflect the IRA ownership. The form is signed by an attorney-in-fact for Mr. Parker on 08/19/2025.
Geoffrey M. Parker, a director of Perrigo Company plc (PRGO), purchased 4,375 ordinary shares on 08/18/2025 at $22.9708 per share. Following the purchase, Mr. Parker is reported to beneficially own 33,287 shares directly and holds additional indirect holdings of 25,879 shares through a revocable trust and 5,500 shares in a Roth IRA, as disclosed on Form 4. The filing was signed by an attorney-in-fact on 08/19/2025 and includes explanatory notes identifying the trust and the Roth IRA as the vehicles for indirect ownership.
Perrigo Company plc insider filing shows EVP & Chief Financial Officer Eduardo Bezerra purchased 3,000 ordinary shares on 08/18/2025 at a reported price of $22.7356 per share, increasing his beneficial holdings to 48,949 shares. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing contains no additional transactions or derivative activity.
FAQ
What is the current stock price of Perrigo Co Plc (PRGO)?
What is the market cap of Perrigo Co Plc (PRGO)?
